Towards robust cell culture processes - Unraveling the impact of media preparation by spectroscopic online monitoring.

PAT cell culture media preparation media quality process robustness scale‐up

Journal

Engineering in life sciences
ISSN: 1618-0240
Titre abrégé: Eng Life Sci
Pays: Germany
ID NLM: 101193313

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 21 03 2019
revised: 12 07 2019
accepted: 31 07 2019
entrez: 7 7 2020
pubmed: 7 7 2020
medline: 7 7 2020
Statut: epublish

Résumé

Biopharmaceutical manufacturing processes can be affected by variability in cell culture media, e.g. caused by raw material impurities. Although efforts have been made in industry and academia to characterize cell culture media and raw materials with advanced analytics, the process of industrial cell culture media preparation itself has not been reported so far. Within this publication, we first compare mid-infrared and two-dimensional fluorescence spectroscopy with respect to their suitability as online monitoring tools during cell culture media preparation, followed by a thorough assessment of the impact of preparation parameters on media quality. Through the application of spectroscopic methods, we can show that media variability and its corresponding root cause can be detected online during the preparation process. This methodology is a powerful tool to avoid batch failure and is a valuable technology for media troubleshooting activities. Moreover, in a design of experiments approach, including additional liquid chromatography-mass spectrometry analytics, it is shown that variable preparation parameters such as temperature, power input and preparation time can have a strong impact on the physico-chemical composition of the media. The effect on cell culture process performance and product quality in subsequent fed-batch processes was also investigated. The presented results reveal the need for online spectroscopic methods during the preparation process and show that media variability can already be introduced by variation in media preparation parameters, with a potential impact on scale-up to a commercial manufacturing process.

Identifiants

pubmed: 32624960
doi: 10.1002/elsc.201900050
pii: ELSC1244
pmc: PMC6999248
doi:

Types de publication

Journal Article

Langues

eng

Pagination

666-680

Informations de copyright

© The Authors. Engineering in Life Sciences published by Wiley-VCH Verlag GmbH & Co. KGaA.

Déclaration de conflit d'intérêts

The authors have declared no conflict of interest.

Références

Biotechnol Prog. 2012 May-Jun;28(3):824-32
pubmed: 22467629
Sensors (Basel). 2015 Apr 30;15(5):10271-91
pubmed: 25942644
J Biotechnol. 2004 Sep 30;113(1-3):211-30
pubmed: 15380657
Biochem J. 1951 Jun;49(1):1-5
pubmed: 14848019
FEBS Lett. 2003 Apr 10;540(1-3):3-6
pubmed: 12681474
J Biotechnol. 2017 Mar 20;246:71-80
pubmed: 28192216
J Chem Technol Biotechnol. 2018 Aug;93(8):2141-2151
pubmed: 30069078
Biotechnol Adv. 2009 Mar-Apr;27(2):153-76
pubmed: 19041387
Anal Chim Acta. 2006 Jul 7;571(2):159-66
pubmed: 17723434
J Biol Chem. 1952 Sep;198(1):353-61
pubmed: 12999750
Anal Chem. 2011 Jul 1;83(13):5422-30
pubmed: 21627078
Biotechnol Prog. 2018 Nov;34(6):1407-1426
pubmed: 30290072
Anal Chem. 2010 Feb 15;82(4):1311-7
pubmed: 20088547
Biotechnol Bioeng. 2010 Oct 1;107(2):290-301
pubmed: 20506397
Anal Bioanal Chem. 2017 Jan;409(3):651-666
pubmed: 27900421
Biotechnol Prog. 2016 Jan-Feb;32(1):74-82
pubmed: 26560839
Anal Chim Acta. 2014 Jan 7;807:111-9
pubmed: 24356227
Anal Bioanal Chem. 2012 Sep;404(4):1211-37
pubmed: 22644146
Bioprocess Biosyst Eng. 2017 Feb;40(2):251-263
pubmed: 27752770
Biochem J. 2008 Nov 15;416(1):77-84
pubmed: 18636967
Cytotechnology. 1995 Jan;19(1):11-26
pubmed: 22358901
Biotechnol Bioeng. 2012 Nov;109(11):2819-28
pubmed: 22566239
J Protein Chem. 1995 May;14(4):225-32
pubmed: 7662110
Biotechnol Prog. 2010 Mar-Apr;26(2):527-31
pubmed: 19938040
Anal Chim Acta. 2014 Aug 20;840:58-67
pubmed: 25086894
Appl Spectrosc. 2011 Nov;65(11):1240-9
pubmed: 22054082
Biochim Biophys Acta. 2012 Feb;1817(2):381-7
pubmed: 22133636
MAbs. 2010 May-Jun;2(3):299-308
pubmed: 20404551
J Inorg Biochem. 2010 Mar;104(3):245-9
pubmed: 20064662
Biotechnol Bioeng. 2019 Jun;116(6):1537-1555
pubmed: 30793282
J Biotechnol. 2013 Dec;168(4):636-45
pubmed: 23948256
Biotechnol Prog. 2017 Jul;33(4):1127-1138
pubmed: 28393480
Biotechnol Prog. 2016 Nov;32(6):1592-1600
pubmed: 27390298
Biotechnol J. 2019 Apr;14(4):e1800352
pubmed: 30485675
Biotechnol Prog. 2011 Sep-Oct;27(5):1339-46
pubmed: 21618724
Biotechnol Bioeng. 1970 May;12(3):409-17
pubmed: 5475079
Science. 1965 Dec 17;150(3703):1593-5
pubmed: 5866655
Biotechnol J. 2013 Jul;8(7):835-46
pubmed: 23589471

Auteurs

Matthias Brunner (M)

Bioprocess Development Biologicals Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany.

Philipp Brosig (P)

Bioprocess Development Biologicals Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany.

Monika Losing (M)

Bioprocess Development Biologicals Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany.

Marco Kunzelmann (M)

Analytical Development Biologicals Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany.

Amandine Calvet (A)

Bioprocess Development Biologicals Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany.

Fabian Stiefel (F)

Bioprocess Development Biologicals Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany.

Jan Bechmann (J)

Bioprocess Development Biologicals Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany.

Andreas Unsoeld (A)

Bioprocess Development Biologicals Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany.

Jochen Schaub (J)

Bioprocess Development Biologicals Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany.

Classifications MeSH